These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 11922591)
21. Plasma amino acid levels in patients with colorectal cancers and liver cirrhosis with hepatocellular carcinoma. Lee JC; Chen MJ; Chang CH; Tiai YF; Lin PW; Lai HS; Wang ST Hepatogastroenterology; 2003; 50(53):1269-73. PubMed ID: 14571716 [TBL] [Abstract][Full Text] [Related]
22. [Primary hepatocellular carcinoma with increased TBG and free thyroxine]. Pedersen OL Ugeskr Laeger; 1974 May; 136(21):1154-5. PubMed ID: 4365593 [No Abstract] [Full Text] [Related]
23. Antithrombin III in patients with hepatocellular carcinoma. Leone G; De Stefano V; Garufi C; Ferrelli R; Cassano A; Grieco A Thromb Haemost; 1987 Dec; 58(4):1093. PubMed ID: 2832966 [No Abstract] [Full Text] [Related]
24. Interleukin-8 serum levels in patients with hepatocellular carcinoma: correlations with clinicopathological features and prognosis. Ren Y; Poon RT; Tsui HT; Chen WH; Li Z; Lau C; Yu WC; Fan ST Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5996-6001. PubMed ID: 14676125 [TBL] [Abstract][Full Text] [Related]
25. Serum high mobility group box chromosomal protein 1 is associated with clinicopathologic features in patients with hepatocellular carcinoma. Cheng BQ; Jia CQ; Liu CT; Lu XF; Zhong N; Zhang ZL; Fan W; Li YQ Dig Liver Dis; 2008 Jun; 40(6):446-52. PubMed ID: 18294942 [TBL] [Abstract][Full Text] [Related]
26. Clinical significance of plasma D-dimer levels and serum VEGF levels in patients with hepatocellular carcinoma. Tseng CS; Lo HW; Chen PH; Chuang WL; Juan CC; Ker CG Hepatogastroenterology; 2004; 51(59):1454-8. PubMed ID: 15362775 [TBL] [Abstract][Full Text] [Related]
27. Alpha-fetoprotein and hepatocellular carcinoma. Colli A; Fraquelli M; Conte D Am J Gastroenterol; 2006 Aug; 101(8):1939; author reply 1940-1. PubMed ID: 16928257 [No Abstract] [Full Text] [Related]
28. Elevated levels of circulating cell-free DNA in the blood of patients with hepatitis C virus-associated hepatocellular carcinoma. Iizuka N; Sakaida I; Moribe T; Fujita N; Miura T; Stark M; Tamatsukuri S; Ishitsuka H; Uchida K; Terai S; Sakamoto K; Tamesa T; Oka M Anticancer Res; 2006; 26(6C):4713-9. PubMed ID: 17214331 [TBL] [Abstract][Full Text] [Related]
29. The analysis of the usefulness of laparoscopic microwave coagulation therapy for hepatocellular carcinoma in patients with poor hepatic reserve by serial measurements of IL-6, cytokine antagonists, and C-reactive protein. Sadamori H; Yagi T; Kanaoka Y; Morimoto Y; Inagaki M; Ishikawa T; Matsukawa H; Matsuda H; Iwagaki H; Tanaka N Surg Endosc; 2003 Mar; 17(3):510-4. PubMed ID: 12399851 [TBL] [Abstract][Full Text] [Related]
31. [Subject diagnostic value of detecting a1pha-fetoprotein variants with a new microspincolumn method in hepatocellular carcinoma]. Xu AF; Wang MC; Sui DM; Yuan YH; Chen G; Lou GQ Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):67-9. PubMed ID: 17429541 [TBL] [Abstract][Full Text] [Related]
32. Selenium, iron, copper, and zinc levels and copper-to-zinc ratios in serum of patients at different stages of viral hepatic diseases. Lin CC; Huang JF; Tsai LY; Huang YL Biol Trace Elem Res; 2006 Jan; 109(1):15-24. PubMed ID: 16388099 [TBL] [Abstract][Full Text] [Related]
33. An analysis of the UNOS liver transplant registry: high serum alpha-fetoprotein does not justify an increase in MELD points for suspected hepatocellular carcinoma. Kemmer N; Neff G; Kaiser T; Zacharias V; Thomas M; Tevar A; Satwah S; Shukla R; Buell J Liver Transpl; 2006 Oct; 12(10):1519-22. PubMed ID: 17004260 [TBL] [Abstract][Full Text] [Related]
34. [Correlation between serum alpha-fetoprotein variant levels in patients with hepatocellular carcinoma and the presence of alpha-fetoprotein mRNA in the circulating blood]. Kang XY; Yin ZF; Qian HH; Wu ZD; Yu ZX; Wu MC Zhonghua Gan Zang Bing Za Zhi; 2003 Jan; 11(1):17-9. PubMed ID: 12546734 [TBL] [Abstract][Full Text] [Related]
35. [Changes of vascular endothelial growth factor and endothelin-1 and nitric oxide in patients with primary hepatocellular carcinoma]. Wun T; Qian HL; Xie L; He LX; Huang DZ Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):441. PubMed ID: 15268819 [No Abstract] [Full Text] [Related]
36. Elevated plasma osteopontin levels in patients with hepatocellular carcinoma. Kim J; Ki SS; Lee SD; Han CJ; Kim YC; Park SH; Cho SY; Hong YJ; Park HY; Lee M; Jung HH; Lee KH; Jeong SH Am J Gastroenterol; 2006 Sep; 101(9):2051-9. PubMed ID: 16848813 [TBL] [Abstract][Full Text] [Related]
37. Clinical significance of elevated alpha-fetoprotein (AFP) in patients with chronic hepatitis C, but not hepatocellular carcinoma. Hu KQ; Kyulo NL; Lim N; Elhazin B; Hillebrand DJ; Bock T Am J Gastroenterol; 2004 May; 99(5):860-5. PubMed ID: 15128351 [TBL] [Abstract][Full Text] [Related]
38. Factors regulating tumor pressure in cases of small hepatocellular carcinoma. Ueki T; Sakaguchi S; Tanaka M; Oka Y; Tohara K; Yao T; Okumura M Hepatogastroenterology; 2007; 54(73):190-4. PubMed ID: 17419258 [TBL] [Abstract][Full Text] [Related]
39. Clinical characteristics among patients with hepatocellular carcinoma according to the serum levels of alpha-fetoprotein and des-y-carboxy prothrombin. Dohmen K; Shigematsu H; Irie K; Ishibashi H Hepatogastroenterology; 2003; 50(54):2072-8. PubMed ID: 14696467 [TBL] [Abstract][Full Text] [Related]
40. Chronic care and monitoring of woodchucks (Marmota monax) during repeated magnetic resonance imaging of the liver. McKenzie EJ; Jackson M; Turner A; Gregorash L; Harapiak L J Am Assoc Lab Anim Sci; 2006 Mar; 45(2):26-30. PubMed ID: 16542039 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]